LONDON (Reuters) - Several drug firms have agreed on a landmark deal to supply up to 200 million doses a year of cut-price pneumococcal vaccines to developing nations, according to the global immunization alliance that is overseeing the deal. Leading manufacturers of such vaccines include GlaxoSmithKline and Pfizer. The agreement is the first under a new scheme called an Advance Market ...

LONDON (Reuters) - Results of a trial of Pfizer's Prevnar 7 vaccine against a major cause of pneumonia and meningitis showed on Wednesday that it can prevent three out of four cases of re-infection in HIV-infected adults in Africa. British researchers who tested the shot in Malawi found it stopped 74 percent of recurrent cases of invasive pneumococcal disease (IPD ...

Nearly 50,000 US medical patients die every year of blood poisoning or pneumonia they picked up in hospital, a study has shown. Hospital-acquired sepsis and pneumonia in 2006 claimed 48,000 lives, led to 2.3 million extra patient-days in hospital and cost 8.1 billion dollars, according to the study, led by researchers from the Center for Disease ...